Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 18/20 | 0.76 |
| ▸ | CCR5 | P51681 | 16/20 | 0.76 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.76 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.76 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.76 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.76 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5768280 | 0.94 | CCR2 (0.76) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3741931 | 0.89 | CCR2 (0.76) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3741934 | 0.89 | CCR2 (0.76) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3734820 | 0.89 | CCR2 (0.76) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3734822 | 0.89 | CCR2 (0.76) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3741926 | 0.89 | CCR2 (0.76) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3734823 | 0.89 | CCR2 (0.76) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL5819718 | 0.89 | CCR2 (0.76) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL5767999 | 0.89 | CCR2 (0.69) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL5768162 | 0.88 | CCR2 (0.59) | CCR2CCR5KCNH2CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1656345-A1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Company (US) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005021500-A1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-03-10 | — | — | WO | disclosed |